Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Researchers identify new drug target for treating neurological disorders

Understanding how the brain processes sweet, bitter and umami tastes may one day help researchers design more effective drugs for neurological disorders.

3 Dec 2019

UC San Diego Health joins national initiative to improve care for seniors

According to the National Council of Aging, approximately 92 percent of seniors have at least one chronic disease and 77 percent have at least two.

2 Dec 2019

New molecular mechanism involved in the regulation of cholesterol movement in cells found

Researchers from the University of Barcelona and the August Pi i Sunyer Biomedical Research Institute found a new molecular mechanism involved in the regulation of the cholesterol movement in cells, an essential process for a proper cell functioning.

2 Dec 2019

Alzheimer's may soon be treated with low dose radiation therapy

A new Phase I study is in the pipeline that would try the effects of low dose radiation therapy for patients with Alzheimer’s disease. The researchers from the Beaumont Research Institute in Royal Oak, Michigan are in the process of recruiting patients for their study. The study is titled, “Study of Low Dose Whole Brain Irradiation in the Treatment of Alzheimer's disease”.

27 Nov 2019

Over €12 million funding to advance autophagy research

Four years ago, Collaborative Research Centre (CRC) 1177 on selective autophagy was established under the leadership of Goethe University - now the German Research Foundation has given the green light for its further funding.

27 Nov 2019

Study shows potential of hydromethylthionine treatment for Alzheimer's disease

In a paper published in today's online issue of the Journal of Alzheimer's Disease (DOI 10.3233/JAD-190772), TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels and pharmacological activity of the drug hydromethylthionine on the brain in over 1,000 patients with mild-to-moderate Alzheimer's disease.

27 Nov 2019

NUS researchers make breakthrough by discovering how the brain encodes memories

NUS researchers have made a breakthrough in the field of cognitive computational neuroscience, by discovering a key aspect of how the brain encodes short-term memories.

27 Nov 2019

New strategy could help cells get rid of disease-related debris

Tohoku University researchers have developed a strategy that could help cells get rid of disease-related debris. Further research could lead to treatments for neurodegenerative and metabolic diseases, Down syndrome, and maybe even aging-related diseases.

27 Nov 2019

FDA-approved anti-inflammatory drug delays onset of ALS in mice

The cause of amyotrophic lateral sclerosis (ALS)--a disabling neurodegenerative disease that affects nerve cells in the brain and spinal cord and leads to weakened muscles and early death--is not fully understood, but accumulating evidence suggests that inflammatory processes may play a role in the initiation and progression of the condition.

27 Nov 2019

Hibernators reveal genetic clues to better understand and treat obesity, metabolic disorders

Hibernation is one of nature's strangest quirks, inducing bears and other mammals to pack on massive weight- amounts that would be unhealthy for humans-;so they can survive months of slumber. Yet when these animals reemerge, they are as fit as ever.

27 Nov 2019

Psychological well-being at 52 years prospectively associated with cognitive function at 69 years

People around the world are living longer, and dementia has consequently become recognized as a public health priority in many countries.

26 Nov 2019

Study finds autism-related genetic mutations in aging brains of Alzheimer's patients

Researchers believe that autism is caused by mutations that occur sporadically in the egg or sperm or during pregnancy.

26 Nov 2019

Oligomerix and Feinstein Institutes publish preclinical data of Alzheimer's disease treatment

Oligomerix, Inc., a privately held company pioneering the development of tau oligomer inhibitors for Alzheimer's disease and related neurodegenerative disorders, and the Feinstein Institutes for Medical Research announced today the publication of preclinical data demonstrating that an oral small molecule drug inhibits the formation of neurotoxic tau oligomers in an animal model of tau aggregation most relevant to AD.

26 Nov 2019

Extra virgin olive oil boosts brain power

Researchers from the Lewis Katz School of Medicine at Temple University have found that extra virgin olive oil (EVOO) could help boost brain power and help halt the progression of the effects of aging on the brain. The study was published in the latest issue of the journal Aging Cell, and it was titled, “Extra virgin olive oil improves synaptic activity, short‐term plasticity, memory, and neuropathology in a tauopathy model.”

26 Nov 2019

Piracetam - an unapproved drug, found in brain supplements

The market is flooded by supplements that claim to boost brain power and stave off dementia. Some of these supplements may not be harmless finds a study. These supplements have been found to contain high portions of an unapproved drug called Piracetam. The study titled, “Presence of Piracetam in Cognitive Enhancement Dietary Supplements,” was published this week in the JAMA Internal Medicine.

26 Nov 2019